<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">perinatology-121</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭНДОКРИНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ЭНДОКРИНОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Метаболический портрет детей с ожирением</article-title><trans-title-group xml:lang="en"><trans-title>The metabolic portrait of obese children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малявская</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Malyavskaya</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., зав. кафедрой педиатрии, проректор по НИР Северного государственного медицинского университета</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры патологической физиологии указанного учреждения</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО «Северный государственный медицинский университет» Минздрава России, Архангельск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Northern State Medical University, Ministry of Health of Russia, Arkhangelsk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>13</day><month>03</month><year>2016</year></pub-date><volume>60</volume><issue>6</issue><fpage>73</fpage><lpage>81</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/121">https://www.ped-perinatology.ru/jour/article/view/121</self-uri><abstract><p>Статья посвящена важной проблеме метаболического синдрома и ожирения, необходимости стратификации атеро- и диабе-тогенного риска в детском и подростковом возрасте. С целью изучения распространенности компонентов метаболического синдрома при нормальной массе тела и выявления метаболических фенотипов ожирения у школьников Архангельска кли-нико-лабораторными методами обследованы 369 детей и подростков в возрасте от 10 до 15 лет с разделением на группы согласно критериям ожирения и выявления различных метаболических вариантов: «метаболически здоровые» без ожирения, «метаболически больные» без ожирения, «метаболически здоровые» с ожирением, «метаболически больные» с общим ожирением. Важным результатом исследования является установленный факт, что метаболические атерогенные нарушения в высоком проценте случаев (43,82%) выявляются у лиц без абдоминального ожирения. Эти пациенты могут представлять часть спектра детей и подростков с синдромом инсулинорезистентности, что подтверждают аномальные величины среднего уровня триглицеридов, холестерина липопротеидов высокой плотности, глюкозы и артериального давления в группе «метаболически больных» детей без ожирения. Исследование показывает, что концепция раннего выявления предикторных признаков должна быть экстраполирована на всю детскую популяцию, вне зависимости от наличия или отсутствия ожирения при направлении усилий на верификацию метаболической активности различных видов жира. В особом внимании и проведения своевременных лечебных и профилактических мер нуждаются «метаболически больные» дети без ожирения с момента идентификации любого компонента метаболического синдрома.</p></abstract><trans-abstract xml:lang="en"><p>The article deals with the important problem of metabohc syndrome and obesity and the need for atherosclerotic and diabetogenic risk stratincation in childhood and adolescence. To study the prevalence of components of the metabohc syndrome at a normal weight and to reveal metabohc phenotypes of obesity in Arkhangelsk schoolchildren, clinical and laboratory tests were used to examine 369 children and adolescents aged 10 to 15 years who were divided into groups according to the criteria of obesity and to identify different metabohc variants: metabohcally healthy normal-weight, metabohcally unhealthy normal-weight, metabohcally healthy obese, and metabohcally unhealthy obese subjects.The important result of the investigation is the established fact that metabohc atherogenic disturbances are detected in a high proportion (43.82%) of individuals without abdominal obesity. These patients may represent a portion of the range of children and adolescents with insulin resistance syndrome, which is confirmed by the abnormal mean levels of triglycerides, high-density lipoprotein cholesterol, glucose, and blood pressure in the group of metabohcally unhealthy normal-weight children.The study shows that the concept of early detection of predictive signs should be extrapolated to the entire pediatric population, regardless of the presence or absence of obesity when efforts are aimed at verifying the metabohc activity of different fat types. The metabohcally unhealthy normal-weight children require special attention and timely therapeutic and preventive measures as soon as any component of the metabohc syndrome is identified.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>подростки</kwd><kwd>метаболический синдром</kwd><kwd>метаболические фенотипы ожирения.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>adolescents</kwd><kwd>metabolic syndrome</kwd><kwd>metabolic phenotypes of obesity.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmeta P., Albertib К. G., Kaufmanc F. et al. The metabolic syndrome in children and adolescents — an IDF consensus report. Pediatric Diabetes 2007; 8: 5: 299-306.</mixed-citation><mixed-citation xml:lang="en">Zimmeta P., Albertib К. G., Kaufmanc F. et al. The metabolic syndrome in children and adolescents — an IDF consensus report. Pediatric Diabetes 2007; 8: 5: 299-306.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ни G., Oiao O., Tuomilehto J. Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women. Arch Intern Med 2004; 164: 1066-1076.</mixed-citation><mixed-citation xml:lang="en">Ни G., Oiao O., Tuomilehto J. Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women. Arch Intern Med 2004; 164: 1066-1076.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Garni A.S., Witt B.J., Howard O.E. Metabolic syndrome and risk of incident cardiovascular events and death. Asystematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.</mixed-citation><mixed-citation xml:lang="en">Garni A.S., Witt B.J., Howard O.E. Metabolic syndrome and risk of incident cardiovascular events and death. Asystematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hubert H.B., Feinleib M., McNamara P.M. et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 969-977.</mixed-citation><mixed-citation xml:lang="en">Hubert H.B., Feinleib M., McNamara P.M. et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 969-977.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">McCrindle B.W., Urbina E.M., Dennison B.A. et al. Scientific Statement From the American Heart. Association Atherosclerosis, Hypertension and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948-1967.</mixed-citation><mixed-citation xml:lang="en">McCrindle B.W., Urbina E.M., Dennison B.A. et al. Scientific Statement From the American Heart. Association Atherosclerosis, Hypertension and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948-1967.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Профилактика сердечно-сосудистых заболеваний в детском и подростковом возрасте. Российские рекомендации. Рос кардиолжурн 2012; 6: Приложение 1: 1—40. (Prevention of cardiovascular disease in childhood and adolescence. Russian recommendations. Roskardiolzhurn2012; 6: Suppl 1:1—40).</mixed-citation><mixed-citation xml:lang="en">Профилактика сердечно-сосудистых заболеваний в детском и подростковом возрасте. Российские рекомендации. Рос кардиолжурн 2012; 6: Приложение 1: 1—40. (Prevention of cardiovascular disease in childhood and adolescence. Russian recommendations. Roskardiolzhurn2012; 6: Suppl 1:1—40).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Малявская СИ., Дворяшина И.В., Терновская В.А Метаболический инсулинорезистентный синдром: диагностика, клиническое значение, педиатрические аспекты. Архангельск 2004; 222. (Malyavskaya S.I., Dvoryashina I.V., Ter-novskaya V.A. Insulinresistant metabolic syndrome: diagnosis, clinical significance, pediatric aspects. ArkhangeFsk 2004; 222.)</mixed-citation><mixed-citation xml:lang="en">Малявская СИ., Дворяшина И.В., Терновская В.А Метаболический инсулинорезистентный синдром: диагностика, клиническое значение, педиатрические аспекты. Архангельск 2004; 222. (Malyavskaya S.I., Dvoryashina I.V., Ter-novskaya V.A. Insulinresistant metabolic syndrome: diagnosis, clinical significance, pediatric aspects. ArkhangeFsk 2004; 222.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Малявская СИ. Педиатрический метаболический синдром: состояние высокого риска. Педиатрия 2010; 89: 4: 119—122. (Malyavskaya S.I. Pediatric metabolic syndrome: the state of high risk. Pediatriya 2010; 89: 4: 119-122.)</mixed-citation><mixed-citation xml:lang="en">Малявская СИ. Педиатрический метаболический синдром: состояние высокого риска. Педиатрия 2010; 89: 4: 119—122. (Malyavskaya S.I. Pediatric metabolic syndrome: the state of high risk. Pediatriya 2010; 89: 4: 119-122.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Calcaterra V., Klersy C, Muratori T. et al. Prevalence of metabolic syndrome in children and adolescents with varying degrees of obesity. Clin Endocrinol 2008; 68: 6: 868-872.</mixed-citation><mixed-citation xml:lang="en">Calcaterra V., Klersy C, Muratori T. et al. Prevalence of metabolic syndrome in children and adolescents with varying degrees of obesity. Clin Endocrinol 2008; 68: 6: 868-872.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ahrens O.W., Moreno L.A., Marild S. et al. Metabolic syndrome in young children: definitions and results of the IDEF-ICS study. Intern J Obes 2014; 38: S4-S14.</mixed-citation><mixed-citation xml:lang="en">Ahrens O.W., Moreno L.A., Marild S. et al. Metabolic syndrome in young children: definitions and results of the IDEF-ICS study. Intern J Obes 2014; 38: S4-S14.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Чумакова Г.А., Веселовская Н.Г., Гриценко О.В. и др. Метаболический синдром: сложные и нерешенные проблемы. Рос кардиол журн 2014; 3: 63—71. (Chumako-va G.A., Veselovskaya N.G., Gritsenko O.V. et al. Metabolic syndrome: a challenging and unsolved problems. Ros kardiol zhurn2014; 3: 63-71.)</mixed-citation><mixed-citation xml:lang="en">Чумакова Г.А., Веселовская Н.Г., Гриценко О.В. и др. Метаболический синдром: сложные и нерешенные проблемы. Рос кардиол журн 2014; 3: 63—71. (Chumako-va G.A., Veselovskaya N.G., Gritsenko O.V. et al. Metabolic syndrome: a challenging and unsolved problems. Ros kardiol zhurn2014; 3: 63-71.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Козлова Л.В., Бекезин В.В., Козлов СБ. и др. Метаболический синдром у детей и подростков с ожирением: диагностика, критерии рабочей классификации, особенности лечения. Педиатрия 2009; 88: 6: 142-150. (Kozlova L.V., Bekezin V.V., Kozlov S.B. et al. Metabolic syndrome in children and adolescents with obesity: diagnosis, criteria working classification, peculiarities of treatment. Pediatriya 2009; 88: 6: 142-150.)</mixed-citation><mixed-citation xml:lang="en">Козлова Л.В., Бекезин В.В., Козлов СБ. и др. Метаболический синдром у детей и подростков с ожирением: диагностика, критерии рабочей классификации, особенности лечения. Педиатрия 2009; 88: 6: 142-150. (Kozlova L.V., Bekezin V.V., Kozlov S.B. et al. Metabolic syndrome in children and adolescents with obesity: diagnosis, criteria working classification, peculiarities of treatment. Pediatriya 2009; 88: 6: 142-150.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bjorntorp P. Visceral Obesity: "Civilization Syndrome". Obes Res 1993; 1: 3: 206-222.</mixed-citation><mixed-citation xml:lang="en">Bjorntorp P. Visceral Obesity: "Civilization Syndrome". Obes Res 1993; 1: 3: 206-222.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kvist H, Chowdhury V.B., Grandgard U. et al. Total and visceral adipose-tissue volumes derived from measurement with computed tomography in adult men and women: predictive equations. AmerJ Clin Nutr 1988; 48: 1351-1361.</mixed-citation><mixed-citation xml:lang="en">Kvist H, Chowdhury V.B., Grandgard U. et al. Total and visceral adipose-tissue volumes derived from measurement with computed tomography in adult men and women: predictive equations. AmerJ Clin Nutr 1988; 48: 1351-1361.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Teixeira T.F.S., Alves R.D.M., Moreira A.P.B. et al. Main characteristics of metabolically obese normal weight and met-abolically healthy obese phenotypes. Nutrition Reviews 2015; 73: 3: 175-190.</mixed-citation><mixed-citation xml:lang="en">Teixeira T.F.S., Alves R.D.M., Moreira A.P.B. et al. Main characteristics of metabolically obese normal weight and met-abolically healthy obese phenotypes. Nutrition Reviews 2015; 73: 3: 175-190.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Blxxher S., Schwarz P. Metabolically healthy obesity from childhood to adulthood — Does weight status alone matter? Metabolism 2014; 63: 9: 1084-1092.</mixed-citation><mixed-citation xml:lang="en">Blxxher S., Schwarz P. Metabolically healthy obesity from childhood to adulthood — Does weight status alone matter? Metabolism 2014; 63: 9: 1084-1092.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Гинзбург М.М., Крюков HH Ожирение. Влияние на развитие метаболического синдрома. Профилактика и лечение. М: Медпрактика 2002; 128. (Ginzburg M.M., KryukovN.N. Ozhirenie. Influence on the development of metabolic syndrome. Prevention and treatment. M: Medpraktika2002; 128.)</mixed-citation><mixed-citation xml:lang="en">Гинзбург М.М., Крюков HH Ожирение. Влияние на развитие метаболического синдрома. Профилактика и лечение. М: Медпрактика 2002; 128. (Ginzburg M.M., KryukovN.N. Ozhirenie. Influence on the development of metabolic syndrome. Prevention and treatment. M: Medpraktika2002; 128.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Берштпейн Л.М., Коваленко ИГ «Метаболически здоровые» лица с ожирением и метаболические признаки ожирения у лиц с нормальной массой тела: что за этим стоит? Проблэндокринол2010; 3: 48—51. (BershteynL.M., Kova-lenko I.G. «Metabolically healthy» individuals with obesity and metabolic signs of obesity in persons with normal body weight: what's in it?) Probl endokrinol 2010; 3:48-51.)</mixed-citation><mixed-citation xml:lang="en">Берштпейн Л.М., Коваленко ИГ «Метаболически здоровые» лица с ожирением и метаболические признаки ожирения у лиц с нормальной массой тела: что за этим стоит? Проблэндокринол2010; 3: 48—51. (BershteynL.M., Kova-lenko I.G. «Metabolically healthy» individuals with obesity and metabolic signs of obesity in persons with normal body weight: what's in it?) Probl endokrinol 2010; 3:48-51.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vague J. La differentiation sexuelle, facteur determinant des formes del'obesite. Press Med 1947; 55: 339-340.</mixed-citation><mixed-citation xml:lang="en">Vague J. La differentiation sexuelle, facteur determinant des formes del'obesite. Press Med 1947; 55: 339-340.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ruderman N.B., Schneider S.H., Berchtold P. The metabolically obese, normal weight individual. Am J Clin Nutr 1981; 34: 1617-1621.</mixed-citation><mixed-citation xml:lang="en">Ruderman N.B., Schneider S.H., Berchtold P. The metabolically obese, normal weight individual. Am J Clin Nutr 1981; 34: 1617-1621.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Reaven G.M. Banting lecture 1988. Role of insulin resis-tance in human disease. Diabetes 1988; 37: 1595-1607.</mixed-citation><mixed-citation xml:lang="en">Reaven G.M. Banting lecture 1988. Role of insulin resis-tance in human disease. Diabetes 1988; 37: 1595-1607.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 1996; 20: 4: 291-302.</mixed-citation><mixed-citation xml:lang="en">Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 1996; 20: 4: 291-302.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bjorntorp P. Regional patterns of fat distribution. Ann Intern Med 1985; 103: 994-995.</mixed-citation><mixed-citation xml:lang="en">Bjorntorp P. Regional patterns of fat distribution. Ann Intern Med 1985; 103: 994-995.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Carey D.G.P. Abdominal obesity. Curr Opin Lipidol 1998; 9: 35-40.</mixed-citation><mixed-citation xml:lang="en">Carey D.G.P. Abdominal obesity. Curr Opin Lipidol 1998; 9: 35-40.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sjostrom CD., Fissner Г., Sjostrom F. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS intervention study. Obes Res 1997; 5: 6: 519-530.</mixed-citation><mixed-citation xml:lang="en">Sjostrom CD., Fissner Г., Sjostrom F. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS intervention study. Obes Res 1997; 5: 6: 519-530.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ruderman N., Chisholm D., Pi-Sunyer X. et al. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.</mixed-citation><mixed-citation xml:lang="en">Ruderman N., Chisholm D., Pi-Sunyer X. et al. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rishi P. Is it Finally Time to Dispel the Concept of Metabol-ically-Healthy Obesity? J Amer College Cardiol 2014; 63: 24: 2687-2688.</mixed-citation><mixed-citation xml:lang="en">Rishi P. Is it Finally Time to Dispel the Concept of Metabol-ically-Healthy Obesity? J Amer College Cardiol 2014; 63: 24: 2687-2688.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Norbert S., Hans-Ulrich H, Frank H.B. et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabet Endocrinol 2013; 1: 2: 152—162.</mixed-citation><mixed-citation xml:lang="en">Norbert S., Hans-Ulrich H, Frank H.B. et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabet Endocrinol 2013; 1: 2: 152—162.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Allan C.A., Strauss B.J., McFachlan R.I. Body composition, metabolic syndrome and testosterone in ageing men. Int J Im-pot Res 2007; 19: 448-457.</mixed-citation><mixed-citation xml:lang="en">Allan C.A., Strauss B.J., McFachlan R.I. Body composition, metabolic syndrome and testosterone in ageing men. Int J Im-pot Res 2007; 19: 448-457.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Succurro E., MariniM.A., Frontoni S. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 2008; 16: 1881-1886."</mixed-citation><mixed-citation xml:lang="en">Succurro E., MariniM.A., Frontoni S. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 2008; 16: 1881-1886."</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Barter P., McPherson Y.R., Song К et al. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 2007; 92: 6: 2041-2045.</mixed-citation><mixed-citation xml:lang="en">Barter P., McPherson Y.R., Song К et al. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 2007; 92: 6: 2041-2045.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Karelis A.D., Faraj M., Bastard J.P. et al. The metabolicafly healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 7: 4145-4150.</mixed-citation><mixed-citation xml:lang="en">Karelis A.D., Faraj M., Bastard J.P. et al. The metabolicafly healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 7: 4145-4150.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Karelis A.D., St-Pierre D.H., Conus F. et al. Metabolic and body composition factors in subgroups of obesity. J Clin Endocrinol Metab 2004; 89: 8: 2569-2575.</mixed-citation><mixed-citation xml:lang="en">Karelis A.D., St-Pierre D.H., Conus F. et al. Metabolic and body composition factors in subgroups of obesity. J Clin Endocrinol Metab 2004; 89: 8: 2569-2575.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Thalmann S., Meier C.A. Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res 2007; 75: 4: 690—701.</mixed-citation><mixed-citation xml:lang="en">Thalmann S., Meier C.A. Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res 2007; 75: 4: 690—701.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">ShaharyarS., Roberson F.F., JamalO. etal. Obesity and metabolic phenotypes (metabolicafly healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a Large Healthy Brazilian Population. J Obes 2015; 2015: http://dx.doi. org/10.1155/2015/178526.</mixed-citation><mixed-citation xml:lang="en">ShaharyarS., Roberson F.F., JamalO. etal. Obesity and metabolic phenotypes (metabolicafly healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a Large Healthy Brazilian Population. J Obes 2015; 2015: http://dx.doi. org/10.1155/2015/178526.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">TchernofA., DespresJ.-P. Pathophysiology of Human Visceral Obesity: An Update. Physiol Rev Publ 2013; 93: 1: 359-404.</mixed-citation><mixed-citation xml:lang="en">TchernofA., DespresJ.-P. Pathophysiology of Human Visceral Obesity: An Update. Physiol Rev Publ 2013; 93: 1: 359-404.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 7121: 847-853.</mixed-citation><mixed-citation xml:lang="en">Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 7121: 847-853.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kelley D.E., Leland T.F., Troost F. et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278: 5: E941-E948.</mixed-citation><mixed-citation xml:lang="en">Kelley D.E., Leland T.F., Troost F. et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278: 5: E941-E948.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 5: 911-920.</mixed-citation><mixed-citation xml:lang="en">Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 5: 911-920.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Romero-Corral A., Somers V.K., Sierra-Johnson J. et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 6:737—746.</mixed-citation><mixed-citation xml:lang="en">Romero-Corral A., Somers V.K., Sierra-Johnson J. et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 6:737—746.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Kramer C.K., Zinman В., Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013; 159: 11: 758-769.</mixed-citation><mixed-citation xml:lang="en">Kramer C.K., Zinman В., Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013; 159: 11: 758-769.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Wet-Ostaptchouk J.V., Nuotio M.L., Slagter S.N. et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis often large cohort studies. BMC Endocrine Dis 2014; 1: 9: http://www. biomedcentral.com/1472-6823/14/9.</mixed-citation><mixed-citation xml:lang="en">Wet-Ostaptchouk J.V., Nuotio M.L., Slagter S.N. et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis often large cohort studies. BMC Endocrine Dis 2014; 1: 9: http://www. biomedcentral.com/1472-6823/14/9.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Denis G.V., Obin M.S. «Metabolically healthy obesity»: origins and implications. Mol Aspects Med 2013; 34: 1: 59—70.</mixed-citation><mixed-citation xml:lang="en">Denis G.V., Obin M.S. «Metabolically healthy obesity»: origins and implications. Mol Aspects Med 2013; 34: 1: 59—70.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Rey-L6pez, J.P., de Rezende L.F., Pastor-Valero M. et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014; 10: 781-790.</mixed-citation><mixed-citation xml:lang="en">Rey-L6pez, J.P., de Rezende L.F., Pastor-Valero M. et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014; 10: 781-790.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Blither M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 1: 38-43.</mixed-citation><mixed-citation xml:lang="en">Blither M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 1: 38-43.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Stefan N., Schick F., Hating H.U. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371: 23: 2236-2237.</mixed-citation><mixed-citation xml:lang="en">Stefan N., Schick F., Hating H.U. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371: 23: 2236-2237.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Rosito G.A., Massaro J.M., Hoffmann U. et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 5: 605—613.</mixed-citation><mixed-citation xml:lang="en">Rosito G.A., Massaro J.M., Hoffmann U. et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 5: 605—613.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Бердышева О.И., Вахлова И.В., Зайкова И.О. и др. Ожирение и метаболический синдром у детей. Урал мед журн 2011; 7: 102-106. (Berdysheva O.I., Vakhlova I.V., Zayko-va I.O. et al. Obesity and metabolic syndrome in children. Ural med zhurn 2011; 7: 102-106.)</mixed-citation><mixed-citation xml:lang="en">Бердышева О.И., Вахлова И.В., Зайкова И.О. и др. Ожирение и метаболический синдром у детей. Урал мед журн 2011; 7: 102-106. (Berdysheva O.I., Vakhlova I.V., Zayko-va I.O. et al. Obesity and metabolic syndrome in children. Ural med zhurn 2011; 7: 102-106.)</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Fox C.S., Massaro J.M., Hoffmann U. et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 1: 39-48.</mixed-citation><mixed-citation xml:lang="en">Fox C.S., Massaro J.M., Hoffmann U. et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 1: 39-48.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Oliveros E., Somers V.K., Sochor O. et al. The Concept of Normal Weight Obesity. Prog Cardiovasc Dis 2014; 56: 4: 426-433.</mixed-citation><mixed-citation xml:lang="en">Oliveros E., Somers V.K., Sochor O. et al. The Concept of Normal Weight Obesity. Prog Cardiovasc Dis 2014; 56: 4: 426-433.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Shah R.V., Murthy V.L., Abbasi S.A. et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imag2014; 12:1221-1235.</mixed-citation><mixed-citation xml:lang="en">Shah R.V., Murthy V.L., Abbasi S.A. et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imag2014; 12:1221-1235.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Flynn J. Metabolic Syndrome as a Predictor of Cardivascular Risk in Children and Adolescents. Am J Hypertens 2007; 20: 8: 883.</mixed-citation><mixed-citation xml:lang="en">Flynn J. Metabolic Syndrome as a Predictor of Cardivascular Risk in Children and Adolescents. Am J Hypertens 2007; 20: 8: 883.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Shargorodsky M. Vascular Impact of Metabolic Syndrome in Subjects with Normal Weight, Overweight, or Obesity: Is Normal Weight Sufficient for Vascular Health? J Am Coll Nutr 2015; 24: 1-6.</mixed-citation><mixed-citation xml:lang="en">Shargorodsky M. Vascular Impact of Metabolic Syndrome in Subjects with Normal Weight, Overweight, or Obesity: Is Normal Weight Sufficient for Vascular Health? J Am Coll Nutr 2015; 24: 1-6.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Bradshaw P.T., Monda K.L., Stevens J. Metabolic Syndrome in Healthy Obese, Overweight and Normal Weight Individuals: The Atherosclerosis Risk in Communities Study. Obesity 2013; 21: 203-209.</mixed-citation><mixed-citation xml:lang="en">Bradshaw P.T., Monda K.L., Stevens J. Metabolic Syndrome in Healthy Obese, Overweight and Normal Weight Individuals: The Atherosclerosis Risk in Communities Study. Obesity 2013; 21: 203-209.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Qorbani M., Kelishadi R., Farrokhi-Khajeh-Pasha Y. et al. Association of Anthropometric Measures with Cardiovascular Risk Factors and Metabolic Syndrome in Normal-Weight Children and Adolescents: The CASPIAN III Study. Obes Facts 2013; 6: 483-492.</mixed-citation><mixed-citation xml:lang="en">Qorbani M., Kelishadi R., Farrokhi-Khajeh-Pasha Y. et al. Association of Anthropometric Measures with Cardiovascular Risk Factors and Metabolic Syndrome in Normal-Weight Children and Adolescents: The CASPIAN III Study. Obes Facts 2013; 6: 483-492.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Surya M., Artham M.D., Lavie C.J. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox and recommendations for weight loss. Ochsner J2009; 9: 3:124—132.</mixed-citation><mixed-citation xml:lang="en">Surya M., Artham M.D., Lavie C.J. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox and recommendations for weight loss. Ochsner J2009; 9: 3:124—132.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">De Schutter A., Lavie C.J., Patel D.A. et al. Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr Opin Clin Nutr Metab Care 2013; 16:5:517-524.</mixed-citation><mixed-citation xml:lang="en">De Schutter A., Lavie C.J., Patel D.A. et al. Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr Opin Clin Nutr Metab Care 2013; 16:5:517-524.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Huang В., Rodreiguez, B.L., Burchfiel CM. et al. Associations of adiposity with prevalent coronary heart disease among elderly men: the Honolulu Heart Program. Int J Obes Relat Metab Disord 1997; 21: 5: 340-348.</mixed-citation><mixed-citation xml:lang="en">Huang В., Rodreiguez, B.L., Burchfiel CM. et al. Associations of adiposity with prevalent coronary heart disease among elderly men: the Honolulu Heart Program. Int J Obes Relat Metab Disord 1997; 21: 5: 340-348.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Cole T.J., Bellizzi M.C., Flegal KM. et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240.</mixed-citation><mixed-citation xml:lang="en">Cole T.J., Bellizzi M.C., Flegal KM. et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Малявская СИ., Лебедев А.В., Терновская В.А. Значение хронической бессимптомной гиперурикемии как маркера атерогенного риска у детей. Кардиология 2007; 47: 3: 62—66. (Malyavskaya S.I., Lebedev A.V., Ternovskaya V.A. The significance of asymptomatic chronic hyperuricemia as a marker of atherogenic risk in children. Kardiologiya 2007; 47: 3: 62—66.)</mixed-citation><mixed-citation xml:lang="en">Малявская СИ., Лебедев А.В., Терновская В.А. Значение хронической бессимптомной гиперурикемии как маркера атерогенного риска у детей. Кардиология 2007; 47: 3: 62—66. (Malyavskaya S.I., Lebedev A.V., Ternovskaya V.A. The significance of asymptomatic chronic hyperuricemia as a marker of atherogenic risk in children. Kardiologiya 2007; 47: 3: 62—66.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
